119 related articles for article (PubMed ID: 1702632)
1. Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine.
Schwartz EL; Chamberlin H; Brechbühl AB
Biochem Pharmacol; 1990 Dec; 40(11):2449-55. PubMed ID: 1702632
[TBL] [Abstract][Full Text] [Related]
2. Enhanced mitogenic responsiveness to granulocyte-macrophage colony-stimulating factor in HL-60 promyelocytic leukemia cells upon induction of differentiation.
Schwartz EL; Maher AM
Cancer Res; 1988 May; 48(10):2683-7. PubMed ID: 2834046
[TBL] [Abstract][Full Text] [Related]
3. Regulation of c-myc expression by granulocyte-macrophage colony-stimulating factor in human leukemia cells.
Schwartz EL; Chamberlin H; Brechbühl AB
Blood; 1991 Jun; 77(12):2716-23. PubMed ID: 1646047
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
Cheng HW; Armstrong RD; Sadée W
Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells.
French BT; Patrick DE; Grever MR; Trewyn RW
Cancer Chemother Pharmacol; 1990; 27(3):171-7. PubMed ID: 2265452
[TBL] [Abstract][Full Text] [Related]
6. Queuine, a tRNA anticodon wobble base, maintains the proliferative and pluripotent potential of HL-60 cells in the presence of the differentiating agent 6-thioguanine.
French BT; Patrick DE; Grever MR; Trewyn RW
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):370-4. PubMed ID: 1988936
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
Ishiguro K; Sartorelli AC
Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
[TBL] [Abstract][Full Text] [Related]
9. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation.
Wu J; Zhu JQ; Han KK; Zhu DX
Oncogene; 1990 Jun; 5(6):873-7. PubMed ID: 2141686
[TBL] [Abstract][Full Text] [Related]
10. Anti-c-myc DNA increases differentiation and decreases colony formation by HL-60 cells.
Wickstrom EL; Bacon TA; Gonzalez A; Lyman GH; Wickstrom E
In Vitro Cell Dev Biol; 1989 Mar; 25(3 Pt 1):297-302. PubMed ID: 2647708
[TBL] [Abstract][Full Text] [Related]
11. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media.
Bacon TA; Wickstrom E
Oncogene Res; 1991; 6(1):21-32. PubMed ID: 1997946
[TBL] [Abstract][Full Text] [Related]
12. Regulation of proliferation in a murine colony-stimulating factor-dependent myeloid cell line: superinduction of c-fos by the growth inhibitor 8-Br-cyclic adenosine 3':5' monophosphate.
Harel-Bellan A; Farrar WL
J Cell Biochem; 1988 Nov; 38(3):145-53. PubMed ID: 3068231
[TBL] [Abstract][Full Text] [Related]
13. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
Darling D; Tavassoli M; Linskens MH; Farzaneh F
Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells.
Sakashita A; Nakamaki T; Tsuruoka N; Honma Y; Hozumi M
Leukemia; 1991 Jan; 5(1):26-31. PubMed ID: 1705636
[TBL] [Abstract][Full Text] [Related]
15. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
Stöcker U; Schaefer A; Marquardt H
Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
[TBL] [Abstract][Full Text] [Related]
16. Retinoic-acid-induced modulation of c-myc not dependent on its continued presence: possible role in pre-commitment for HL-60 cells.
Guernsey DL; Yen A
Int J Cancer; 1988 Oct; 42(4):576-81. PubMed ID: 2459072
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of spontaneous hypoxanthine phosphoribosyltransferase mutations in thioguanine-resistant HL-60 human leukemia cells.
Monnat RJ
Cancer Res; 1989 Jan; 49(1):81-7. PubMed ID: 2908855
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
Ishiguro K; Schwartz EL; Sartorelli AC
J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines.
Arsura M; Luchetti MM; Erba E; Golay J; Rambaldi A; Introna M
Blood; 1994 Apr; 83(7):1778-90. PubMed ID: 8142646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
